Pseudomonas otitis externa u psów – metody rozpoznawania i leczenia

Piśmiennictwo

1. Barrasa J.L.M., Lupiola G.P., González L.Z., Tejedor J.M.T.: Antibacterial susceptibility patterns of Pseudomonas strains isolated from chronic canine otitis externa. „J Vet Med B Infect Dis Vet Public Health”, 2000, 47, 191-6.
2. Buckley L.M., McEwan N.A., Nuttall T.: Tris-EDTA significantly enhances antibiotic efficacy against multidrug-resistant Pseudomonas aeruginosa in vitro. „Vet Dermatol”, 2013, 24, 519-e122.
3. Carlotti D.N., Guaguere E., Koch H.J.: Marbofloxacin for the systemic treatment of Pseudomonas spp. suppurative otitis externa in the dog. [In:] von Tscharner C., Kwochka K.W., Willemse T.: Advances in Veterinary Dermatology. Oxford: Butterworth Heinemann, 1998.
4. Cole L.K., Kwochka K.W., Kowalski J.J.: Microbial flora and antimicrobial susceptibility patterns of isolated pathogens from the horizontal ear canal and middle ear in dogs with otitis media. „J Amer Vet Med Assoc”, 1998, 212, 534-538.
5. Dégi J., Cristina R.T., Stancu A.: Otitis externa caused by bacteria of the genus Pseudomonas in dogs. „Journal of Lucrari Stiintifice Medicina Veterinara”, 2017, 63 (1), 410-415.
6. Engelen M., De Bock M., Hare J., Goossens L.: Effectiveness of an oticproduct containing miconazole, polymyxin B and prednisolone in the treatment of canine otitis externa: multi-site field trial in the US and Canada. „Int J Appl Res Vet Med”, 2010, 8, 21-30.
7. Griffin C.: Pseudomonas otitis. World Small Animal Veterinary Association World Congress Proceedings, 2006.
8. Jerzsele Á., Pásztiné-Gere E.: Evaluating synergy between marbofloxacin and gentamicin in Pseudomonas aeruginosa strains isolated from dogs with otitis externa. „Acta Microbiol Immunol Hung”, 2015, 62, 45-55.
9. Lloyd D.H.: Antibiotic resistance. The challenge in small animal dermatology. Proceedings of the British Veterinary Dermatology Study Group, 1998, 8-11.
10. May E.R., Conklin K.A., Bemis D.A.: Antibacterial effect of N-acetylcysteine on common canine otitis externa isolates. „Vet Dermatol”, 2016, 27, 188-e47.
11. Morris D.O.: Medical therapy of otitis externa and otitis media. „Vet Clin Small Anim”, 2004, 34, 541-555.
12. Nuttall T.J: Use of ticarcillin in the management of canine otitis externa complicated by Pseudomonas aeruginosa. „J Small Anim Pract”, 1998, 39, 165-168.
13. Paterson S., Matyskiewicz W.: A study to evaluate the primary causes associated with Pseudomonas otitis in 60 dogs. „J Small Anim Pract”, 2018, 59, 238-242.
14. Pietschmann S., Hoffmann K., Voget M.: Synergistic effects of miconazole and polymyxin B on microbial pathogens. „Vet Res Commun”, 2008, 33, 489-505.
15. Pye C.C., Singh A., Scott J.: Evaluation of the impact of tromethamine edetate disodium dihydrate on antimicrobial susceptibility of Pseudomonas aeruginosa in biofilm in vitro. „Vet Dermatol”, 2014, 25, 120-e34.
16. Pye C.: Pseudomonas otitis externa in dogs. „Can Vet J”, 2018, 9 (11), 1231-1234.
17. Robson D., Burton G., Bassett R.: Correlation between topical antibiotic selection, in vitro bacterial antibiotic sensitivity and clinical response in 16 cases of canine otitis externa complicated by Pseudomonas aeruginosa. Proc North American Veterinary Dermatology Forum; Portland, Oregon, April 14-17, 2010.
18. Rougier S., Borell D., Pheulpin S., Woehrlé F., Boisraméa B: Comparative study of two antimicrobial/anti-inflammatory formulations in the treatment of canine otitis externa. „Vet Dermatol”, 2005, 16, 299-307.
19. Saridomichelakis M.N., Farmaki R., Leontides L.S., Koutinas A.F.: Aetiology of canine otitis externa: a retrospective study of 100 cases. „Vet Derm”, 2007, 18, 341-347.
20. Schick A.E., Angus J.C., Coyner K.S.: Variability of laboratory identification and antibiotic susceptibility reporting of Pseudomonas spp. isolates from dogs with chronic otitis externa. „Vet Dermatol”, 2007, 18, 120-6.
21. Seol B., Naglic T., Madic J., Bedekovic M.: In Vitro Antimicrobial Susceptibility of 183 Pseudomonas aeruginosa Strains Isolated from Dogs to Selected Antipseudomonal Agents. „J Vet Med B”, 2002, 49, 188-192.
22. Święcicka N., Bernacka H., Fac E., Zawiślak J.: Prevalence and commonest causes for otitis externa in dogs from two polish veterinary clinics. „Bulg J Vet Med”, 2015, 18, 65-73.
23. Swinney A., Fazakerley J., McEwan N., Nuttall T.: Comparative in vitro antimicrobial efficacy of commercial ear cleaners. „Vet Dermatol”, 2008, 19, 373-9.
24. Eliasi U.L., Sebola D., Oguttu J.W., Qekwana D.N.: Antimicrobial resistance patterns of Pseudomonas aeruginosa isolated from canine clinical cases at a veterinary academic hospital in South Africa. „J S Afr Vet Assoc”, 2020, 91, 2052.
25. White S.D.: Medical Treatment of Otitis externa. World Small Animal Veterinary Association World Congress Proceedings, 2003.
26. Wildermuth B.E., Griffin C.E., Rosenkrantz W.S., Boord M.J.: Susceptibility of Pseudomonas isolates from the ears and skin of dogs to enrofloxacin, marbofloxacin, and ciprofloxacin. „J Am Anim Hosp Assoc”, 2007, 43, 337-41.
27. Yukawa S., Tsuyuki Y., Sato T., Fukuda A., Usui M., Tamura Y.: Antimicrobial Resistance of Pseudomonas aeruginosa Isolated from Dogs and Cats in Primary Veterinary Hospitals in Japan. „Jpn J Infect Dis”, 2017, 70, 461-463.

dr hab. Marcin Szczepanik, prof. uczelni
Zakład Diagnostyki Klinicznej
i Dermatologii Weterynaryjnej
Wydział Medycyny Weterynaryjnej
Uniwersytet Przyrodniczy w Lublinie
ul. Głęboka 30, 20-612 Lublin